2023-09-29 12:15:23

Biohaven's ALS drug fails to meet study goals

Logo Nasdaq
Nasdaq
By Reuters

Sept 29 (Reuters) - Biohaven Pharmaceutical Holding Company Ltd BHVN.N said on Thursday its experimental drug to treat amyotrophic lateral sclerosis (ALS) failed to meet the main goal and secondary goals of a mid-to-late stage study.

The migraine drugmaker in May agreed to an $11.6 billion acquisition deal by Pfizer Inc PFE.N, which plans to spin off its non-migraine drugs into a new publicly traded company.

AD
AD

(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)

(([email protected]; www.twitter.com/Manaswrites15;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Continue read on nasdaq.com

AD
Logo Investing.com
MarketsBy Reuters2023-09-29 12:28:09
Reuters. FILE PHOTO: The logo for Biohaven Pharmaceutical Holding Company is displayed on a screen during the company's IPO on the floor of the New York...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-20 10:53:49
Sept 20 (Reuters) - Merck & Co Inc MRK.N said on Tuesday it would start a new late-stage trial of its HIV drug, islatravir, months after the U.S. Food...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-23 12:40:31
Sept 23 (Reuters) - The U.S. Centers for Disease Control and Prevention reported on Thursday that 4.4 million people had received updated COVID-19 booster...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-20 13:08:55
Sept 20 (Reuters) - Walgreens Boots Alliance WBA.O said on Tuesday it would buy the remaining stake in specialty pharmacy company Shields Health Solutions...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-22 20:35:29
(Adds details from advisory committee meeting) Sept 22 (Reuters) - A panel of U.S. Food and Drug Administration advisers voted in favor of Ferring...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-13 10:38:53
Adds trial details, background, shares Sept 13 (Reuters) - Akero Therapeutics Inc AKRO.O said on Tuesday its lead experimental drug met the main goal for...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-13 10:14:03
Sept 13 (Reuters) - Akero Therapeutics Inc AKRO.O said on Tuesday its lead experimental drug met the main goal in treatment of a type of fatty liver disease....

Logo WJXT
PoliticsBy Matthew Perrone2024-09-02 17:27:59
WASHINGTON Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou...

Logo U.S. News & World Report
PoliticsBy Associated Press2024-09-02 17:27:59
By MATTHEW PERRONE, AP Health Writer WASHINGTON (AP) Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-22 17:05:35
Sept 22 (Reuters) - Meta Platform's META.O Instagram was down for thousands of users on Thursday, according to outage tracking website Downdetector.com....

Logo Nasdaq
Business / FinanceBy Reuters2024-09-22 18:40:02
Sept 22 (Reuters) - FedEx Corp FDX.N on Thursday posted a 5.45% rise in first-quarter revenue at $23.2 billion, from a year earlier. (Reporting by Nathan...

Logo U.S. News & World Report
PoliticsBy Reuters2024-09-07 22:34:33
(Reuters) - Amylyx Pharmaceuticals Inc's drug for amyotrophic lateral sclerosis (ALS) won the support of external advisers to the U.S. Food and Drug...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-26 10:54:24
Sept 26 (Reuters) - Pfizer Inc PFE.N on Monday submitted an application to the U.S. Food and Drug Administration (FDA) requesting the authorization of an...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-20 11:25:45
Adds background Sept 20 (Reuters) - Merck & Co Inc MRK.N said on Tuesday it would start fresh late-stage studies of its HIV treatment, islatravir, months...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-21 21:52:24
By Mrinalika Roy Sept 21 (Reuters) - Longer-term use and early initiation of Biogen Inc's BIIB.O experimental treatment for an inherited form of amyotrophic...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-20 22:55:31
Sept 21 (Reuters) - Australian power producer Viva Energy VEA.AXsaid on Wednesday it will acquire the fuel and convenience retailing business of Coles Group...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-22 22:21:33
Sept 23 (Reuters) - Australian miner OZ Minerals Ltd said on Friday it will invest about A$1.7 billion ($1.13 billion) to develop the West Musgrave...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-22 06:27:30
Sept 22 (Reuters) - British drugmaker GSK GSK.L said on Thursday it would take a stake in Spero Therapeutics SPRO.O as part of a licensing agreement for the...

Logo Nasdaq
MarketsBy Rtt News2024-09-08 04:46:38
(RTTNews) - Amylyx Pharmaceuticals Inc. (AMLX) announced that the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs...

Logo Nasdaq
Business / FinanceBy Reuters2024-09-21 05:17:02
ZURICH, Sept 21 (Reuters) - Novartis AG NOVN.S plans to ask the U.S. Supreme court to uphold the validity of a patent it holds on the dosing regimen for...